English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 848760      Online Users : 1311
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/12199


    Title: Prognostic and clinicopathologic associations of Casein Kinase (CK) 1 alpha in acral lentiginous melanoma
    Other Titles: Prognostic and clinicopathologic associations of Casein Kinase (CK) 1 α in acral lentiginous melanoma
    Authors: Chang, C;Huang, S;Ito, T;Lo, Y;Shen, C;Tsai, K;Wu, T;Hsu, Y;Chang, K;Lin, T
    Contributors: National Institute of Cancer Research
    Abstract: Acral lentiginous melanoma (ALM), presenting on the palms of the hands, the soles of the feet, and the subungual area, is the most common type melanoma in Asian. Casein kinase 1α (CK1α, encoded by the CSNK1A1 gene) is involved in multiple cellular processes including gene transcription, cell division, nuclear localization, DNA repair, and carcinogenesis. CK1α has been reported as tumor promoter or tumor suppressor in different tumor types and tumor sites. In this study, we aim to investigate the role of CK1α in ALM. A total of 158 cases of ALM registered in three medical centers, two in Taiwan and one in Japan, were enrolled. We analyzed the prognostic impact of CK1α on the survival of ALM patients using the clinicopathological data and immunohistochemistry in 158 formalin-fixed paraffin-embedded samples, and examined the CSNK1A1 gene copy number variation (CNV) using droplet digital PCR in 69 samples. Patients with CK1α-high expression had significantly shorter melanoma-specific survival compared to those with CK1α-low expression (5-year survival, 45.2 % vs. 91.6 %; P < 0.001). 92.8% (64/69) of ALM had increased CNV of CSNK1A1. Higher CSNK1A1 CNV was associated with more advanced Breslow thickness. In conclusion, overexpression of CK1α is an adverse prognostic factor in ALM. CK1α may function as a tumor promoter in ALM, and a potential therapeutic target of ALM.
    Date: 2019-09
    Relation: Journal of Investigative Dermatology. 2019 Sep;139(9):S299.
    Link to: http://dx.doi.org/10.1016/j.jid.2019.07.541
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0022-202X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000485661500486
    Appears in Collections:[沈哲宏] 會議論文/會議摘要

    Files in This Item:

    File Description SizeFormat
    ISI000485661500486.pdf198KbAdobe PDF249View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback